HighTower Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
MPI
HighTower Advisors's CLB Position: Q4 2019 in Review
HighTower Advisors sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 4,564 shares — an estimated $213K sold.
HighTower Advisors first reported a position in CLB in Q1 2015 and held it in 18 quarters. The position peaked at $4.37M in Q1 2016. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.
- HighTower Advisors reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
- HighTower Advisors sold 4,564 Core Laboratories shares in Q4 2019, an estimated $213K.
- HighTower Advisors first reported a position in Core Laboratories in Q1 2015 and held it in 18 quarters.
- HighTower Advisors's Core Laboratories position peaked at $4.37M in Q1 2016.
- 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.
Based on HighTower Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.